CNS Drugs

, Volume 26, Issue 7, pp 571–580

Management of Cluster Headache

Therapy In Practice

Abstract

The prevalence of cluster headache is 0.1% and cluster headache is often not diagnosed or misdiagnosed as migraine or sinusitis. In cluster headache there is often a considerable diagnostic delay — an average of 7 years in a population-based survey. Cluster headache is characterized by very severe or severe orbital or periorbital pain with a duration of 15–180 minutes. The cluster headache attacks are accompanied by characteristic associated unilateral symptoms such as tearing, nasal congestion and/or rhinorrhoea, eyelid oedema, miosis and/or ptosis. In addition, there is a sense of restlessness and agitation. Patients may have up to eight attacks per day. Episodic cluster headache (ECH) occurs in clusters of weeks to months duration, whereas chronic cluster headache (CCH) attacks occur for more than 1 year without remissions.

Management of cluster headache is divided into acute attack treatment and prophylactic treatment. In ECH and CCH the attacks can be treated with oxygen (12L/min) or subcutaneous sumatriptan 6 mg. For both oxygen and sumatriptan there are two randomized, placebo-controlled trials demonstrating efficacy.

In both ECH and CCH, verapamil is the prophylactic drug of choice. Verapamil 360 mg/day was found to be superior to placebo in one clinical trial. In clinical practice, daily doses of 480–720 mg are mostly used. Thus, the dose of verapamil used in cluster headache treatment may be double the dose used in cardiology, and with the higher doses the PR interval should be checked with an ECG. At the start of a cluster, transitional preventive treatment such as corticosteroids or greater occipital nerve blockade can be given.

In CCH and in long-standing clusters of ECH, lithium, methysergide, topiramate, valproic acid and ergotamine tartrate can be used as add-on prophylactic treatment.

In drug-resistant CCH, neuromodulation with either occipital nerve stimulation or deep brain stimulation of the hypothalamus is an alternative treatment strategy.

For most cluster headache patients there are fairly good treatment options both for acute attacks and for prophylaxis. The big problem is the diagnosis of cluster headache as demonstrated by the diagnostic delay of 7 years. However, the relatively short-lasting attack of pain in one eye with typical associated symptoms should lead the family doctor to suspect cluster headache resulting in a referral to a neurologist or a headache centre with experience in the treatment of cluster headache.

References

  1. 1.
    May A. Cluster headache: pathogenesis, diagnosis and management. Lancet 2005; 366(9488): 843–55PubMedCrossRefGoogle Scholar
  2. 2.
    Matharu MS, Goadsby PJ. Trigeminal autonomic cephalalgias: diagnosis and management. In: Silberstein SD, Lipton RB, Dodick DW, editors. Wolff’s headache and other head pain. 8th ed. New York: Oxford University Press, 2008: 379–430Google Scholar
  3. 3.
    Ashkenazi A, Schwedt T. Cluster headache-acute and prophylactic treatment. Headache 2011; 51(2): 272–86PubMedCrossRefGoogle Scholar
  4. 4.
    Headache Classification Committee of the International Headache Society. The international classification of headache disorders: 2nd ed. Cephalalgia 2004; 24 Suppl. 1: 9–160Google Scholar
  5. 5.
    Goadsby P, Tfelt-Hansen P. Cluster headache: introduction and epidemiology. In: Olesen J, Tfelt-Hansen P, Goadsby PJ, et al, editors. The headaches. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins, 2006: 743–5Google Scholar
  6. 6.
    Klapper JA, Klapper A, Voss T. The misdiagnosis of cluster headache: a nonclinic, population-based, internet survey. Headache 2000; 40(9): 730–5PubMedCrossRefGoogle Scholar
  7. 7.
    Jensen RM, Lyngberg A, Jensen RH. Burden of cluster headache. Cephalalgia 2007; 27(6): 535–41PubMedCrossRefGoogle Scholar
  8. 8.
    May A, Leone M, Áfra J, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 2006; 13(10): 1066–77PubMedCrossRefGoogle Scholar
  9. 9.
    Tfelt-Hansen P, Paulson OB, Krabbe AA. Invasive adenoma of the pituitary gland and chronic migrainous neuralgia: a rare coincidence or a causal relationship? Cephalalgia 1982; 2(1): 25–8PubMedCrossRefGoogle Scholar
  10. 10.
    Law S, Derry S, Moore RA. Triptans for acute cluster headache. Cochrane Database Syst Rev 2010; (4): CD008042PubMedGoogle Scholar
  11. 11.
    Tyagi A, Matharu M. Evidence base for the medical treatment used in cluster headache. Curr Pain Headache Rep 2009; 13(2): 168–78PubMedCrossRefGoogle Scholar
  12. 12.
    Fogan L. Treatment of cluster headache: a double-blind comparison of oxygen v air inhalation. Arch Neurol 1985; 42(4): 362–3PubMedCrossRefGoogle Scholar
  13. 13.
    Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA 2009; 302(22): 2451–7PubMedCrossRefGoogle Scholar
  14. 14.
    Gaul C, Finken J, Bierman J, et al. Treatment costs and indirect costs of cluster headache: a health economic analysis. Cephalalgia 2011; 31(16): 1664–72PubMedCrossRefGoogle Scholar
  15. 15.
    Rozen TD, Fishman RS. Inhaled oxygen and cluster headache sufferers in the United States: use, efficacy and economics: results from the United States Cluster Headache Survey. Headache 2011; 51(2): 191–200PubMedCrossRefGoogle Scholar
  16. 16.
    The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Eng J Med 1991; 325(5): 322–6CrossRefGoogle Scholar
  17. 17.
    Ekbom K, Monstad I, Prusinski A, et al. Sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group. Acta Neurol Scand 1993; 88(1): 63–9PubMedCrossRefGoogle Scholar
  18. 18.
    van Vliet JA, Bahra A, Martin V, et al. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology 2003; 60(4): 630–3PubMedCrossRefGoogle Scholar
  19. 19.
    Cittadini E, May A, Straube A, et al. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol 2006; 63(11): 1537–42PubMedCrossRefGoogle Scholar
  20. 20.
    Rapoport AM, Mathew NT, Silberstein SD, et al. Zolmitriptan nasal spray in the acute treatment of headache: a double-blind study. Neurology 2007; 69(9): 821–6PubMedCrossRefGoogle Scholar
  21. 21.
    Hedlund C, Rapoport A, Dodick DW, et al. Zolmitriptan nasal spray in the acute treatment of cluster headache: a metaanalysis of two studies. Headache 2009; 49(9): 1315–23PubMedCrossRefGoogle Scholar
  22. 22.
    Bahra A, Gawel MJ, Hardebo JE, et al. Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 2000; 54(9): 1832–9PubMedCrossRefGoogle Scholar
  23. 23.
    Matharu MS, Levy MJ, Meeran K, et al. Subcutaneous octreotide in cluster headache: subcutaneous sumatriptan randomized, placebo-controlled, double-blind cross-over study. Ann Neurol 2004; 56(4): 488–94PubMedCrossRefGoogle Scholar
  24. 24.
    Di Sabato F, Fusco BM, Pelaia P, et al. Hyperbaric oxygen therapy in cluster headache. Pain 1993; 52(2): 243–5PubMedCrossRefGoogle Scholar
  25. 25.
    Nilsson Remahl AI, Ansjön R, Lind F, et al. Hyperbaric oxygen treatment of active cluster headache: a double-blind placebo-controlled cross-over study. Cephalalgia 2002; 22(9): 730–9PubMedCrossRefGoogle Scholar
  26. 26.
    Paemeleire K, Bahra A, Evers S, et al. Medication-overuse headache in patients with cluster headache. Neurology 2006; 67: 109–13PubMedCrossRefGoogle Scholar
  27. 27.
    Paemeleire K, Evers S, Goadsby PJ. Medication-overuse headache in patients with cluster headache. Curr Pain Headache Rep 2008; 12: 122–7PubMedCrossRefGoogle Scholar
  28. 28.
    Goadsby PJ, Cohen AS, Matharu MS. Trigeminal autonomic cephalalgias: diagnosis and treatment. Curr Neurol Neurosci Rep 2007; 7(2): 117–25PubMedCrossRefGoogle Scholar
  29. 29.
    Antonaci F, Costa A, Candeloro E, et al. Single high-dose steroid treatment in episodic cluster headache. Cephalalgia 2005; 25(4): 290–5PubMedCrossRefGoogle Scholar
  30. 30.
    Couch Jr JR, Ziegler DK. Prednisone therapy for cluster headache. Headache 1978; 18(4): 219–21PubMedCrossRefGoogle Scholar
  31. 31.
    Ambrosini A, Vandenheede M, Rossi P, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain 2005; 118(1–2): 92–6PubMedCrossRefGoogle Scholar
  32. 32.
    Dodick DW. Suboccipital steroid injections for cluster headache. Lancet Neurol 2011; 10(10): 867–9PubMedCrossRefGoogle Scholar
  33. 33.
    Leroux E, Valade D, Taifas I, et al. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2011; 10(10): 891–7PubMedCrossRefGoogle Scholar
  34. 34.
    Tfelt-Hansen P, Tfelt-Hansen J. Verapamil for cluster headache: clinical pharmacology and possible mode of action. Headache 2009; 49(1): 117–25PubMedCrossRefGoogle Scholar
  35. 35.
    Cohen AS, Matharu MS, Goadsby PJ. Electrocardiographic abnormalities in patients with cluster headache treated with verapamil. Neurology 2007; 69(7): 668–75PubMedCrossRefGoogle Scholar
  36. 36.
    Bussone G, Leone M, Peccarisi C, et al. Double-blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990; 30(7): 411–7PubMedCrossRefGoogle Scholar
  37. 37.
    Leone M, Rapoport A. Preventive and surgical management of cluster headaches. In: Olesen J, Goadsby PJ, Ramadan NM, et al., editors. The headaches. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins, 2006: 809–14Google Scholar
  38. 38.
    Magis D, Allena M, Bolla M, et al. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol 2007; 6(4): 314–21PubMedCrossRefGoogle Scholar
  39. 39.
    Goadsby PJ, Schoenen J, Ferrari MD, et al. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia 2006; 26(9): 1168–70PubMedCrossRefGoogle Scholar
  40. 40.
    Matharu MS, Boes CJ, Goadsby PJ. Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs 2003; 63(16): 1637–77PubMedCrossRefGoogle Scholar
  41. 41.
    May A. Hypothalamic deep-brain stimulation: target and potential mechanism for the treatment of cluster headache. Cephalalgia 2008; 28(7): 799–803PubMedCrossRefGoogle Scholar
  42. 42.
    Leone M, Proietti Cecchini A, Franzini A, et al. Lessons from 8 years’ experience of hypothalamic stimulation in cluster headache. Cephalalgia 2008; 28(7): 787–97PubMedCrossRefGoogle Scholar
  43. 43.
    Burns B, Watkins L, Goadsby PJ. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology 2009; 72(4): 341–5PubMedCrossRefGoogle Scholar
  44. 44.
    Ambrosini A. Occipital nerve stimulation for intractable cluster headache. Lancet 2007; 369(9567): 1063–5PubMedCrossRefGoogle Scholar
  45. 45.
    Leone M, Franzini A, Cacchini AP, et al. Hypothalamic deep brain stimulation in the treatment of chronic cluster headache. Ther Adv Neurol Disord 2010; 3(3): 187–95PubMedCrossRefGoogle Scholar
  46. 46.
    Fontaine D, Lazothes Y, Mertens P, et al. Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension. J Headache Pain 2010; 11(1): 23–31PubMedCrossRefGoogle Scholar
  47. 47.
    Schoenen J, Di Clemente L, Vandenheede M, et al. Hypothalamic stimulation in chroinc cluster headache: a pilot study of efficacy and mode of action. Brain 2005; 128(Pt 4): 940–7PubMedCrossRefGoogle Scholar
  48. 48.
    Schwedt TJ, Dodick DW, Trentman TL, et al. Response to occipital nerve block is not useful in predicting efficacy of occipital nerve stimulation. Cephalalgia 2007; 27(3): 271–4PubMedCrossRefGoogle Scholar
  49. 49.
    Sluder G. The role of the sphenopalatine ganglion (or Meckel’s) ganglion in nasal headaches. New York Med J 1908; 87: 989–90Google Scholar
  50. 50.
    Ansarinia M, Rezai A, Tepper SJ, et al. Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches. Headache 2010; 50(7): 1164–74PubMedCrossRefGoogle Scholar
  51. 51.
    Leone M, D’Amico D, Frediani F, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology 2000; 54(6): 1382–5PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2012

Authors and Affiliations

  1. 1.Danish Headache Center, Department of NeurologyUniversity of Copenhagen, Glostrup HospitalGlostrupDenmark

Personalised recommendations